期刊文献+

临床药师参与肝移植术后伴急性免疫排异反应患者的药学监护 被引量:1

Pharmaceutical Care for Liver Transplantation Patient with Acute Rejection
下载PDF
导出
摘要 目的:探讨临床药师在肝移植术后伴急性免疫排异反应患者药物治疗中的作用。方法:临床药师参与1例肝移植术后出现急性免疫排异反应患者的治疗,通过分析患者病情,查阅临床指南和文献,协助医师优化抗排异、抗感染的药物治疗方案。为及时控制急性免疫排异反应,临床药师建议在大剂量糖皮质激素冲击治疗的基础上,迅速增加他克莫司胶囊的剂量。患者多次痰培养出鲍曼不动杆菌,药师综合分析患者病情后,建议将抗感染方案调整为注射用替加环素首剂100 mg,维持剂量50 mg,静脉滴注,每12 h给药1次;注射用头孢哌酮舒巴坦2 g,静脉滴注,每12 h给药1次;注射用舒巴坦1 g,静脉滴注,每12 h给药1次。为减轻患者经济负担,临床药师建议降阶梯使用抗真菌药,将注射用伏立康唑调整为氟康唑片。药师对患者所用药物的不良反应保持全程监护。结果:临床药师的建议被采纳,患者急性免疫排异反应得到有效控制,未出现感染,治疗15 d后由肝移植监护室转入普通病房。结论:临床药师参与肝移植术后伴急性免疫排异反应患者的治疗,可协助医师完善用药方案,促进临床合理用药。 OBJECTIVE:To investigate the role of clinical pharmacists in the treatment of one liver transplantation patient with acute rejection. METHODS: The clinical pharmacists participated into the treatment of one liver trarrsplantation patient with acute rejection. Through analyzing patients' disease conditions and researching the clinical guide and literature, the clinical pharmacists assisted the clinicians to optimize the treatment regimen of anti-rejection and anti-infection drugs. In order to control the acute rejection, a higher dose of tacrolimus was suggested as a complement to the high-dose corticosteroid by clinical pharmacists. For the culture of sputum showed growth of Acinetobacter baumanii with several times, the adjustment of the anti-infection drugs was advised after analyzing the infections risks by clinical pharmacists: tigecycline with loading dose of 100 mg, maintenance dose of 50 mg, ivgtt, q12 h; cefperazone-sulbactam 2 g, ivgtt, q12 h; sulbactam 1 g, ivgtt, q12 h. The substitution of voriconazole by fluconazole was also advised to decrease the financial burden of the patient. The pharmacy guardianship was kept for the whole treatment process. RESULTS: The suggestions from the clinical pharmacists were adopted. After treatment for 15 days, the acute refection was effectively controlled and the patient was transferred from the liver transplant care unit to the ordinary department without infection symptoms. CONCLUSIONS : The participation of clinical pharmacists in the treatment of liver transplantation patient with acute rejection can optimize the drug therapy, and promote the rational drug use in clinic.
出处 《中国医院用药评价与分析》 2017年第2期251-253,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 2015年浙江省医药卫生科技项目(No.2015KYA095GPR17)
关键词 肝移植 急性免疫排异 临床药师 药学监护 Liver transplantation Acute rejection Clinical pharmacists Pharmaceutical care
  • 相关文献

参考文献6

二级参考文献74

  • 1任南,文细毛,吴安华.全国医院感染横断面调查结果的变化趋势研究[J].中国感染控制杂志,2007,6(1):16-18. 被引量:352
  • 2卫生部医政司.医务人员手卫生规范(WS/T313—2009)[S].2009.
  • 3国家中医药管理局.医院感染暴发报告及处理管理规范[S].北京:中华人民共和国卫生部,2009.
  • 4.抗菌药物临床应用指导原则[S].[S].中华医学会,2004.184.
  • 5Peleg AY, Seifert H, Paterson DLAeinetobaeter baumannii: emergence of a successful pathogen. Clin Micmbiol Rev,2008,21 : 538-582.
  • 6Falagas ME, Koletsi PK, Bliziotis IA.The diversity of definitions of muhidrug-resistant(MDR) and pandrug-resistant (PDR) Aeinetohaeter bsumannli and Pseudomonas aeruginosa.J Med Microbiol, 2006,55: 1619-1629.
  • 7Paterson DL, Doi Y.A step closer to extreme drug resistance(XDR) in gram-negative bacilli.Clin Infect Dis,2007,45: 1179-1181.
  • 8Falagas ME, Karageorgopoulos DE.Pandrug resistance(PDR), extensive drug resistance(XDR), and muhidrug resistance(MDR) among Gram- negative bacilli: need for international harmonization in terminology.Clin Infect Dis, 2008,46: 1121-1122; author reply 1122.
  • 9Zhou H, Yang Q, Yu YS, et al. Clonal Spread of Imipenem-resistant Aeinetobaeter baumannii among different cities of China.J Clin Mierubiol, 2007,45 : 4054-4057.
  • 10Perez F, Hujer AM, Hujer KM, et al.Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2007,51: 3471-3484.

共引文献1562

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部